Sabra Health Care REIT (SBRA) Scheduled to Post Quarterly Earnings on Wednesday

Sabra Health Care REIT (NASDAQ:SBRA) will be issuing its Q4 2017 quarterly earnings data after the market closes on Wednesday, February 21st. Analysts expect the company to announce earnings of $0.30 per share for the quarter.

Shares of Sabra Health Care REIT (NASDAQ SBRA) opened at $16.80 on Wednesday. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.89. Sabra Health Care REIT has a fifty-two week low of $16.02 and a fifty-two week high of $29.10. The stock has a market cap of $2,990.00, a PE ratio of 21.54, a price-to-earnings-growth ratio of 2.27 and a beta of 0.74.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, February 28th. Shareholders of record on Thursday, February 15th will be issued a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a yield of 10.71%. The ex-dividend date is Wednesday, February 14th. Sabra Health Care REIT’s dividend payout ratio (DPR) is 266.67%.

SBRA has been the subject of a number of recent analyst reports. Zacks Investment Research cut shares of Sabra Health Care REIT from a “hold” rating to a “sell” rating in a report on Wednesday, January 17th. Stifel Nicolaus reiterated a “hold” rating and issued a $22.00 target price on shares of Sabra Health Care REIT in a research note on Friday, November 3rd. ValuEngine cut shares of Sabra Health Care REIT from a “buy” rating to a “hold” rating in a research note on Sunday, December 31st. TheStreet cut shares of Sabra Health Care REIT from a “b-” rating to a “c” rating in a research note on Friday, November 3rd. Finally, SunTrust Banks reiterated a “buy” rating and issued a $25.00 target price on shares of Sabra Health Care REIT in a research note on Friday, November 3rd. Three analysts have rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $24.10.

In related news, Director Milton J. Walters sold 4,615 shares of the stock in a transaction dated Thursday, November 30th. The shares were sold at an average price of $19.18, for a total value of $88,515.70. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 2.60% of the stock is currently owned by company insiders.

COPYRIGHT VIOLATION WARNING: “Sabra Health Care REIT (SBRA) Scheduled to Post Quarterly Earnings on Wednesday” was reported by American Banking News and is the property of of American Banking News. If you are reading this news story on another domain, it was illegally copied and republished in violation of United States and international trademark & copyright law. The correct version of this news story can be read at https://www.americanbankingnews.com/2018/02/14/sabra-health-care-reit-sbra-scheduled-to-post-quarterly-earnings-on-wednesday.html.

Sabra Health Care REIT Company Profile

Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.

Earnings History for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply